<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4805">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01831102</url>
  </required_header>
  <id_info>
    <org_study_id>10-1260</org_study_id>
    <nct_id>NCT01831102</nct_id>
  </id_info>
  <brief_title>Adiponectin and Ethnic Differences in Insulin Resistance</brief_title>
  <official_title>Adiponectin as an Independent Determinant of Ethnic Differences in Insulin Resistance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this protocol is to measure and compare levels of the circulating protein
      adiponectin and adiponectin's association with insulin sensitivity in Mexican Americans and
      non-Latino white subjects. The investigators also aimed to examine associations between
      nutritional factors and adiponectin levels.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>total adiponectin concentration</measure>
    <time_frame>measured once during second study visit, in fasting condition</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>Measured once, during second study visit.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Calculated from insulin and glucose values obtained during IV glucose tolerance test.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">43</enrollment>
  <condition>Insulin Resistance</condition>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>non-Latino white</arm_group_label>
    <description>no Latino ancestry, Caucasian</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mexican American</arm_group_label>
    <description>Mexican American ancestry</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>none- observational study</intervention_name>
    <arm_group_label>non-Latino white</arm_group_label>
    <arm_group_label>Mexican American</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Community sample
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-60 years of age

          -  BMI 20.0-34.9 m/kg2

          -  Mexican American with at least 3 grandparents born in Mexico or white with no
             grandparents of Latino descent.

        Exclusion Criteria:

          -  pregnancy

          -  breastfeeding

          -  diabetes mellitus

          -  blood pressure &gt; 160/100 mmHg

          -  creatinine &gt; 1.5 mg/dl or glomerular filtration rate (GFR) &lt; 60

          -  liver function tests &gt; 3x upper limit of normal (ULN)

          -  h/o heart failure

          -  h/o eating disorder
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rocio Pereira, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado Anschutz Medical Center</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 9, 2013</lastchanged_date>
  <firstreceived_date>April 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>insulin resistance</keyword>
  <keyword>ethnic disparities</keyword>
  <keyword>adiponectin</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
